The efficacy and safety of the low-thalidomide dose CTD (cyclophosphamide, thalidomide, dexamethasone) regimen in patients with multiple myeloma--a report by the Polish Myeloma Study Group.
scientific article published on 2 June 2010
Author/s
author: Iwona Hus, Norbert Grzasko, Jaroslaw Piszcz, Anna Dmoszyńska, Wieslaw Jedrzejczak, Aleksander Skotnicki, Grzegorz Charlinski, Janusz Kłoczko, Adam Walter-Croneck, Lidia Usnarska-Zubkiewicz
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.